Business Wire

Futur Publishes Annual and Sustainability Report for 2024

Share

Today, Futur Pension AB (publ) publishes its Annual and Sustainability Report for 2024. Read it at www.futur.se/financial-information

We are pleased to note that Futur’s customers overall have experienced strong returns in 2024. In particular, customers with exposure to global equities, led by the U.S. market, have seen significant growth of their capital. Thereto, we are proud of high inflows of new savings and pension capital.

In line with last years, Futur has continued to invest heavily in its technology platform to ensure a high level of service and cost efficiency.

“For the coming years, we see great opportunities to continue growing by developing innovative and efficient services for savings and pension together with our partners. In 2025, we will continue our investments in digital self-service solutions to strengthen our position as the obvious choice for savings and pensions. We also look forward to more and deeper collaborations throughout the year,” says Torgny Johansson, CEO of Futur.

Key highlights 2024:

  • New digital self-service interface for private customers which has contributed to reducing routine calls to customer service by more than 30%
  • Awarded most innovative company and the company with the best product range in Origo’s annual survey among financial advisors in Sweden
  • 4 new partners and 23,000 new customers
  • 80% Y-on-Y growth in the occupational pension portfolio bond product
  • Continued revenue growth (+24% Y-on-Y) and 50% higher net inflows than in 2023

Futur’s positive development continued in 2024, and the profit grew by 33% to 420 million SEK (compared to SEK 316m in 2023). This increase is explained by growing net inflows, strong returns on customers’ capital, and cost efficiency.

Key financial figures 2024 (2023):

  • Revenue 998 MKR (806)
  • Sales costs 459 MKR (371)
  • Admin costs 119 MKR (119)
  • Profit 420 MKR (316)
  • Proposed dividend 350 MKR (275) corresponding to over 80% of profit

Read more in the annual report at www.futur.se/financial-information

Futur provides digital infrastructure for the savings and pension market. With our modern platform, we efficiently connect products and customers through partners who offer professional advice. Our platform enables partners to offer better savings options cost-effectively, helping more people achieve a richer and more secure future. Futur has more than 50 partners and 300,000 customers, with 235 billion SEK in savings and pension capital. For more information, visit www.futur.se

The information was submitted for publication, through the agency of the contact persons set out above, at 2025-03-17 11:00 CET.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250317622387/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Solidsoft Reply Successfully Integrates the Hellenic Medicines Verification System into the European Medicines Verification Platform18.3.2025 10:00:00 CET | Press release

In collaboration with the Hellenic Medicines Verification Organisation (HMVO), Solidsoft Reply, a Reply Group company specialising in Microsoft Azure cloud-based enterprise solutions, has successfully integrated Greece’s Hellenic Medicines Verification System (HMVS) within the European Hub, delivering the launch on schedule. This achievement enhances Greece’s pharmaceutical landscape and protects its citizens from the growing threat of falsified medications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250318137690/en/ The HMVS now operates as part of the European Medicines Verification System (EMVS), a pan-national platform designed to prevent counterfeit medicines from entering the market and reaching patients. With this launch, Greece joins a growing network of 15 other fully operational and secure National Medicine Verification System (NMVS) platforms across Europe, powered by Solidsoft Reply. The HMVS became fully ope

LUMENION sets new standards with CO2-free process steam for industrial applications18.3.2025 10:00:00 CET | Press release

"Green steam" supply with thermal storage in operation and available for all industrial sectors"Green Discount": solution supports decarbonization while enabling cost-efficient electrification of industrial processes LUMENION has successfully completed the test operation of a plant for the supply of "green steam" in combination with a large-scale thermal storage solution. The completion of this LUMENION solution marks an important milestone on the way to a decarbonized industry. The TÜV-certified system is available for applications in all industrial sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250318462006/en/ LUMENION TES LUMENION's thermal energy storage system uses a few hours of electricity supply to charge and to store energy in the form of heat of up to 600° Celsius. The energy can be charged flexibly at intervals throughout the day and is made available to customers in the form of steam or process heat ove

Japan Sake and Shochu Makers Association: Global Beverage Experts Explore Japan’s Sake, Honkaku Shochu, and Awamori Culture18.3.2025 09:19:00 CET | Press release

The Japan Sake and Shochu Makers Association (JSS) is hosting a special tour inviting top professionals from the global wine and bar industries to explore the depth and heritage of Japan’s sake, honkaku shochu, and awamori culture. This exclusive program offers first-hand experience of Japan’s traditional brewing and distilling techniques, which were recently recognized as a UNESCO Intangible Cultural Heritage. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250316698311/en/ Leading Sommeliers Visiting a Rice Polishing Facility The sake tour brings together leading sommeliers and restaurant beverage directors from around the world to visit select breweries across Japan. Participants dive deep into the production process, learning about rice polishing, fermentation, and aging techniques unique to sake. The itinerary extends beyond brewery visits to an educational institute, offering specialized sessions on yeast selection, aro

Global Trust in Digital Services Declines, Finds Thales18.3.2025 09:00:00 CET | Press release

Thales 2025 Digital Trust Index reveals most industries experienced a decline in consumer trust compared to last year Privacy fears are becoming a major factor in consumer decisions to abandon brands. 82% doing so last year Banking tops the Trust Index for the second year in a row, but levels of trust fall to just 32% among Gen Z customers 33% of consumers voiced frustration with ecommerce, directly caused by bad bots manipulating the customer purchasing process Thales, today announced the findings of its 2025 Digital Trust Index – Consumer Edition, revealing a universal decline in trust for digital services compared to this time last year. Across 13 different sectors, only insurance, banking and Government saw either their trust level remain unchanged or increase very slightly. When asked which sector they trusted with their personal data, not one sector reached above 50% approval. Thales surveyed over 14,000 consumers across 14 countries about their online relationship with brands an

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support18.3.2025 09:00:00 CET | Press release

Biovelocita II attracts robust support from leading pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures The fund has already screened over 300 projects and made several investments into new companies to catalyze transformative innovation in biotechnology Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the final close of Sofinnova Biovelocita II. The fund has exceeded its target, successfully raising €165M, with substantial backing from the top global pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures. This milestone marks a significant expansion of Sofinnova’s biotech acceleration strategy, extending beyond Italy to include France, the United Kingdom, and Denmark, with ambitions to further reach additional European countries in the future. Since its launch, the fund has screened over 300 projects and made several key investments i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye